Inhibition of Maternal-to-Fetal Transfer of IgG Antibodies by FcRn Blockade in a Mouse Model of Arthrogryposis Multiplex Congenita.
Ester CoutinhoLeslie JacobsonAnthony ShockBryan SmithAnthony Christopher VernonAngela VincentPublished in: Neurology(R) neuroimmunology & neuroinflammation (2021)
FcRn blockade is a promising therapeutic strategy to prevent the occurrence of AMC and other human maternal autoantibody-related diseases in the offspring.